Israel Non-alcoholic Steatohepatitis Clinical Trials Market (2025-2031) | Forecast, Companies, Trends, Analysis, Competitive Landscape, Industry, Size & Revenue, Segmentation, Growth, Value, Outlook, Share

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenues & Volume, 2021 & 2031F

3.3 Israel Non-alcoholic Steatohepatitis Clinical Trials Market - Industry Life Cycle

3.4 Israel Non-alcoholic Steatohepatitis Clinical Trials Market - Porter's Five Forces

3.5 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenues & Volume Share, By Phase, 2021 & 2031F

3.6 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenues & Volume Share, By Study Design, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Israel

4.2.2 Growing awareness about the importance of clinical trials for NASH treatment

4.2.3 Favorable government initiatives and funding to support clinical trials in Israel

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for conducting clinical trials in Israel

4.3.2 Limited availability of skilled healthcare professionals for conducting NASH clinical trials in the country

6.1 Israel Non-alcoholic Steatohepatitis Clinical Trials Market, By Phase

6.1.1 Overview and Analysis

6.1.2 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenues & Volume, By Phase, 2021- 2031F

6.1.3 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenues & Volume, By Phase I, 2021- 2031F

6.1.4 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenues & Volume, By Phase II, 2021- 2031F

6.1.5 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenues & Volume, By Phase III, 2021- 2031F

6.1.6 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenues & Volume, By Phase IV, 2021- 2031F

6.2 Israel Non-alcoholic Steatohepatitis Clinical Trials Market, By Study Design

6.2.1 Overview and Analysis

6.2.2 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenues & Volume, By Interventional, 2021- 2031F

6.2.3 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenues & Volume, By Observational, 2021- 2031F

6.2.4 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenues & Volume, By Expanded Access, 2021- 2031F

7.1 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Export to Major Countries

7.2 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Imports from Major Countries

8.1 Patient recruitment rate for NASH clinical trials in Israel

8.2 Retention rate of participants in NASH clinical trials

8.3 Number of research collaborations between Israeli institutions and international organizations for NASH clinical trials.

9.1 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Opportunity Assessment, By Phase, 2021 & 2031F

9.2 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Opportunity Assessment, By Study Design, 2021 & 2031F

10.1 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Revenue Share, By Companies, 2024

10.2 Israel Non-alcoholic Steatohepatitis Clinical Trials Market Competitive Benchmarking, By Operating and Technical Parameters